Clinical Trial Update: Brexpiprazole Treatment for Bipolar I Depression [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating brexpiprazole for bipolar I depression is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• REXULTI (brexpiprazole)

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Bipolar Depression | Phase 3 | Status: RECRUITING